Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.92 (overall 0.56) | 0.92 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 64 | 0.91 |
| pathways Reactome | 7 pathways; mostly vesicle traffic | 1.00 |
Knock down and overexpress DDOST in a dopamine neuron, astrocyte and microglia tri-culture; measure LRRK2 kinase activity (pT73-Rab10) and lysosome position and dopamine neuron survival after α-synuclein fibril challenge.
- Cell type
- a dopamine neuron, astrocyte and microglia tri-culture
- Direction
- Both arms: public data does not say which way helps.
- Molecular readout
- LRRK2 kinase activity (pT73-Rab10) and lysosome position
- Functional readout
- dopamine neuron survival after α-synuclein fibril challenge
- Rule-out
- If neither arm moves LRRK2 kinase activity (pT73-Rab10) by 20% or more against non-targeting and empty-vector controls, across three independent differentiations, the hypothesis is wrong.
- Lab request
- CRISPRi knockdown and lentiviral overexpression of DDOST in a tri-culture of iPSC dopamine neurons, astrocytes and microglia; n = 3 differentiations; readouts: LRRK2 kinase activity (pT73-Rab10) and lysosome position; dopamine neuron survival after α-synuclein fibril challenge. Controls: non-targeting guide, empty vector. About 8 to 10 weeks, most of it differentiation.
Earlier readings: 2026-10-26 0.82; 2026-10-25 0.82; 2026-10-24 0.82; 2026-10-23 0.82.
Sealed predictions
- DDOST in dopamine neurons, braak+0.25 (p 0.517) → -0.35 (p 0.361)receipt 0579
- DDOST in dopamine neurons, braak-0.18 (p 0.266) → -0.05 (p 0.773)receipt 0116
- DDOST in dopamine neurons, resilience-0.06 (p 0.830) → +0.57 (p 0.039)receipt 0117
Swarm cases
receipt 0579: DDOST in dopamine neurons, braak
- power
- full sample -0.08 (p 0.761, n 18), 95% CI -0.53 to +0.40. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.01 (p 0.976, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.05 (p 0.834, n 18). could be the mix.
- skeptic
- leave-one-out range -0.18 to +0.06, sign flips 1; without severely affected donors -0.08 (p 0.761, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DDOST in dopamine neurons.
case closed: nothing better to follow up.
receipt 0117: DDOST in dopamine neurons, resilience
- power
- full sample +0.23 (p 0.247, n 55), 95% CI -0.04 to +0.46. the interval is wide: not enough donors to tell.
- confounder
- adjusted for age, sex and PMI: +0.15 (p 0.449, n 55). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.12 (p 0.542); controlling for it: +0.15 (p 0.436, n 55). could be the mix.
- skeptic
- leave-one-out range +0.15 to +0.30, sign flips 0; without severely affected donors +0.24 (p 0.231, n 46). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "differs in resilient donors (Lewy pathology, no parkinsonism)" for DDOST in dopamine neurons.
case closed: nothing better to follow up.
receipt 0116: DDOST in dopamine neurons, braak
- power
- full sample -0.11 (p 0.311, n 84), 95% CI -0.32 to +0.10. the interval sits on zero: probably nothing there.
- confounder
- adjusted for age, sex and PMI: -0.08 (p 0.492, n 84). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis -0.72 (p 1.8e-14); controlling for it: -0.09 (p 0.420, n 84). could be the mix.
- skeptic
- leave-one-out range -0.14 to -0.08, sign flips 0; without severely affected donors -0.12 (p 0.309, n 75). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DDOST in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts